selected publications
- cGAS inhibition delays TDP-43-driven ALS Pathogenesis. bioRxiv : the preprint server for biology. 2026 Article GET IT
- cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy. bioRxiv : the preprint server for biology. 2026 Article GET IT
-
High-Throughput Screening and Initial SAR Studies Identify a Novel Submicromolar Potent Human cGAS Inhibitor.
ACS chemical biology.
2025
Academic Article
GET IT
Times cited: 1 -
FDA-Approved Fluorine-Containing Molecules in 2024: Significance, Synthesis, and Therapeutic Applications.
Current topics in medicinal chemistry.
2025
Academic Article
GET IT
Times cited: 4 - High-Throughput Screening and Initial SAR Studies Identify a Novel Sub-micromolar Potent Human cGAS Inhibitor. bioRxiv : the preprint server for biology. 2025 Article GET IT
-
Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.
2025
Information Resource
GET IT
Times cited: 11 -
Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience.
Nature neuroscience.
2023
Academic Article
GET IT
Times cited: 193